Faith Davies, MD
Enriched profileProfessor, Department of Medicine, NYU Grossman School of Medicine; Director, Clinical Myeloma Program, Perlmutter Cancer Center; Inaugural Director, Center for Blood Cancers, Perlmutter Cancer Center · NYU Langone Health
Faith Davies is Professor, Department of Medicine, NYU Grossman School of Medicine; Director, Clinical Myeloma Program, Perlmutter Cancer Center; Inaugural Director, Center for Blood Cancers, Perlmutter Cancer Center at NYU Langone Health. OpenAlex indexes 1,151 publications with 40,591 citations (h-index 99); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Faith E. Davies, MD, is Professor, Department of Medicine, NYU Grossman School of Medicine at NYU Langone Health / Perlmutter Cancer Center. The public record shows 1,151 publications with 40,591 citations (h-index 99), centered on Hematology. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 14 companies, 1 NIH-funded awards (2026–2026).
- Most recent indexed publication: 2026 · Blood cancer discovery
- Top research focus: Hematology
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 12 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- UARK 2015-03 A Phase II Trial of a Novel Proteasome/IMiD Combination
Sponsor: University of Arkansas
Industry payments
Updated 27 Aug 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Janssen Global Services, LLCProgram year20257 payments$12,688openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20253 payments
- Janssen Biotech, Inc.Program year20254 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
53.7%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor53.7%Acyclovir100%Part D≥11 patientsNervous system
15.9%Opioid Agonist15.9%Oxycodone Hcl100%Part D<11 patientsCancer & immunology
15.9%Thalidomide Analog15.9%Revlimid100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2026–2026 per NIH RePORTER. The latest:
- Investigating the role of incretin mimetics in reducing the risk of development and progression of multiple myeloma and its precursor conditions
New York University School of Medicine
FY2026$466,125R21CA301170
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Genomic features do not account for differences in multiple myeloma risk by ancestry.
Blood cancer discovery
Article2026 - Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.
Blood cancer discovery
Article2025 - International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.
Journal of clinical oncology
Guideline2025 - Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma.
Clinical cancer research
Article2024 - Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma.
Blood cancer discovery
Article2024
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/faith-davies-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - X / Twitter
x.com/FaithEDavies1
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/nyulangonehealth_dr-faith-davies-a-nationally-renowned-hematology-activity-6922544883979186176-OgH_
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
healthtree.org/myeloma/community/podcasts/essential-research-for-myeloma-cures
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthtree.org ↗ - X / Twitter
x.com/Myeloma_Society/status/1968426613005017237
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- MD/MBBCh
University of Wales College of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →patientpower.info ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →patientpower.info ↗
Editorial & leadership roles
journal and society appointments- Member
HMWG Steering Committee, American Association for Cancer Research
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aacr.org ↗ - Member
Membership Committee, International Myeloma Society
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myelomasociety.org ↗ - Active member
American Society of Hematology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Secondary affiliations
appointments beyond the home institution- Previously Medical Director
Myeloma Institute, and Professor of Medicine, University of Arkansas for Medical Sciences
2019provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - Member
Hematologic Malignancies Working Group (HMWG) Steering Committee, American Association for Cancer Research (AACR)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aacr.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
- Video interview series contributor/author
OncLive (e.g. "Dr Davies on Challenges Experienced When Treating Patients With Multiple Myeloma")
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Harvey Pass, MD
NYU Langone Health
Gareth Morgan, MD
NYU Langone Health
Douglas Kondziolka, MD
NYU Langone Health
Nathan Levin, MD
NYU Langone Health